Steven Oday
Hematology & Oncology · Santa Monica, CANPI 1518070812
Payments from drug & device makers
$3,720,466in general payments, 2019–2025
Across 516 payments — averaging $7210.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$3M
- Incyte Corporation$321K
- E.r. Squibb & Sons, L.L.C.$254K
- Novartis$153K
- Amgen$16K
- Eisai CO., LTD.$14K
- plus $3K from 5 others
General payments by program year
19
20
21
22
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 254 | $2,960,540 |
| Incyte Corporation | 88 | $320,658 |
| E.r. Squibb & Sons, L.L.C. | 141 | $253,667 |
| Novartis | 2 | $152,782 |
| Amgen | 10 | $15,760 |
| Eisai CO., LTD. | 3 | $13,750 |
| Array Biopharma Inc | 12 | $2,617 |
| Bristol Myers Squibb | 3 | $641 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| GT Medical Technologies, Inc | 1 | $17 |
| Gilead | 1 | $12 |
How this compares
$3,720,466 in reported general payments places this provider in the 95th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Santa Monica
- Jonathan GoldmanSanta Monica$35.7M
- Omid HamidSanta Monica$23.7M
- Aditya BardiaSanta Monica$22.1M
- Zev WainbergSanta Monica$19.3M
- Richard FinnSanta Monica$9.9M
- Aaron LisbergSanta Monica$9.6M
- Alain AlgaziSan Francisco$119.2M
- David BerzLos Angeles$43.3M
- Nicholas McAndrewLos Angeles$22.9M
- Joseph TuscanoSacramento$20.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.